MEDIA RELEASE: 20 MAY 2025 The world-leading impact of a Newcastle-based cancer research organisation is in the spotlight this International Clinical Trials Day (Tuesday 20 May), after funding was granted for groundbreaking new research projects. The Trans Tasman Radiation Oncology Group –TROG Cancer Research – has been leading radiation
LATEST NEWS: 15 May 2025 A novel imaging modality aimed at reducing radiation therapy side effects for patients with lung cancer is set to be trialled in Australia, after researchers received a $1.86m National Health and Medical Research Council (NHMRC) grant. The NHMRC Clinical Trials and Cohort Studies Grant
Latest News: 21 April 2025 TROG Cancer Research is among 70 research bodies in Australia that are supporting a national initiative to make existing health and medical research data easier to find, boosting secondary use of valuable clinical trials research data. The Health Studies Australian National Data Asset (HeSANDA)
LATEST NEWS: 15 April 2025 An innovative trial aimed at improving outcomes for patients with brain metastases will progress to the next stage after receiving a $120,000 grant from the Mark Hughes Foundation (MHF) Centre for Brain Cancer Research at the University of Newcastle. Congratulations to Dr Neda Haghighi
LATEST NEWS: 15 April 2025 A record number of consumers joined us for the 2025 TROG Annual Scientific Meeting, as we focused on ways to boost inclusivity, access and consumer collaboration in clinical trials. We were thrilled that more than 15 consumers from across NSW, Queensland and New Zealand
INTERVIEW: 9 April 2025 Professor Bryan Burmeister is one of TROG’s longest standing members, who has contributed to our work in a myriad of ways over the past 30 years. He was TROG Scientific Committee Chair from 2002-2007, Board President from 2007 to 2010 and has led multiple trials.
Latest news: 28 March 2025. TROG Members who have made significant contributions both to the work of TROG and to advancing radiation medicine clinical trial research more broadly were recognised with our 2025 Research Excellence Awards this month. We congratulate the following winners on their well-deserved awards, which were
Latest news: 27 March 2025 With a theme of inclusivity and innovation, our Annual Scientific Meeting (ASM) brought together researchers, health professionals and consumers from across Australia and New Zealand with the common goal of advancing cancer care through vital research. More than 310 delegates gathered for the TROG
5 March 2025: TRIAL UPDATE We’re excited to have now opened all Australian sites for the TROG 21.07 – SOCRATES HCC study, which is investigating the use of an advanced radiotherapy technique for early-stage hepatocellular carcinoma (HCC). With the opening of a clinical trial site at St George Hospital
4 March 2025: A decade on from the last participant completing treatment, the BIG 3-07/TROG 07.01 – DCIS trial is continuing to deliver valuable results. Led by TROG Cancer Research, the international, randomised phase III study aimed to improve the treatment outcomes of women diagnosed with ductal carcinoma in-situ
